Pharmacogenetics and Genomics

Papers
(The median citation count of Pharmacogenetics and Genomics is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-1973
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators12
Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia11
Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients11
Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry10
Regulation of CYP3A4 and CYP3A5 by a lncRNA: a potential underlying mechanism explaining the association between CYP3A4*1G and CYP3A metabolism9
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia9
Incorporating G6PD genotyping to identify patients with G6PD deficiency7
Histone acetylation at the sulfotransferase 1a1 gene is associated with its hepatic expression in normal aging7
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinica6
Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation6
Implementation of pharmacogenomics into inpatient general medicine6
C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in Mestizo patients with metastatic colorectal cancer6
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis6
Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance6
Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma5
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia5
Single Nucleotide Polymorphisms (SNPs) in PRKG1 & SPATA13-AS1 are associated with bronchodilator response: a pilot study during acute asthma exacerbations in African American children5
Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients5
Analytical validation of a laboratory-development multigene pharmacogenetic assay4
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity4
Impact of cytochrome P450 2C19 polymorphisms on the clinical efficacy and safety of voriconazole: an update systematic review and meta-analysis4
MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway4
A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicity4
PharmGKB summary: acyclovir/ganciclovir pathway4
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants4
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis4
Influence of MDR1 gene polymorphism (2677G>T) on expression and function of P-glycoprotein at the blood-brain barrier: utilizing novel P-glycoprotein humanized mice with mutation4
The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia4
NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis4
Striatin genotype-based, mineralocorticoid receptor antagonist-driven clinical trial: study rationale and design3
Genome-wide DNA methylation profile of peripheral blood lymphocytes from subjects with nonsteroidal anti-inflammatory drug-induced respiratory diseases3
Pharmacogenetics: a perspective and preparedness of Pharm-D and medical students in Jordan3
Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy3
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)2
Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis2
Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy2
Annual Scientific Meeting of the Pharmacogenomics Global Research Network (PGRN) June 12-13, 2023 Memphis, TN, USA2
Ligand-specific pharmacogenetic effects of nonsynonymous mutations2
Investigation of pharmacologic interactions between omeprazole and tacrolimus in a membranous nephropathy patient with CYP3A5 nonexpresser: a case report2
Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy2
Pharmacogenetic analysis of canonical versus noncanonical pathway of NF-kB in Crohn’s disease patients under anti-tumor necrosis factor-α treatment2
Bone marrow mesenchymal stem cell-derived exosomes carrying E3 ubiquitin ligase ITCH attenuated cardiomyocyte apoptosis by mediating apoptosis signal-regulated kinase-12
The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs2
Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study2
Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease2
Psychotropic prescribing rates and pharmacogenomic testing implications for autism in the Canadian primary care sentinel surveillance network2
In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4)2
Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension2
Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes2
Comparison of clinical pharmacogenetic recommendations across therapeutic areas2
Sulfamethoxazole-trimethoprim-induced liver injury and genetic polymorphisms of NAT2 and CYP2C9 in Taiwan2
Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes1
Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis1
Influence of CMTM8 polymorphisms on lung cancer susceptibility in the Chinese Han population1
Diversity of oncopharmacogenetic profile within Spanish population1
Establishing national reference materials for genetic testing of cytochrome P4501
PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction1
ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion1
Association of the ACE and AGT gene polymorphisms with global disparities in COVID-19-related deaths1
Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens1
Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase/serine/threonine kinase signaling pathway1
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans1
Pan-cancer single-cell landscape of drug-metabolizing enzyme genes1
N-acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer1
Association of ATP8B3 gene polymorphisms with aspirin-exacerbated respiratory disease in asthmatics1
Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors1
Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative care1
Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram1
Cisplatin-induced ototoxicity: a novel approach to an ancient problem1
Proximal tubular dysfunction related to tenofovir in people living with HIV/AIDS: a pharmacogenetic study1
Pregnane X receptor gene variant rs7643645 and total mortality in subjects with nonalcoholic fatty liver disease1
Association between opioid and dopamine receptor gene polymorphisms OPRM1rs1799971, DAT VNTR9-10 repeat allele, DRD1 rs4532 and DRD2 rs1799732 and alcohol dependence: an ethnicity oriented meta-analys1
Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV1
0.08224892616272